Featured Research

from universities, journals, and other organizations

Regular Use Of Asthma Drugs Poses Respiratory, Cardiac Dangers

Date:
June 18, 2004
Source:
Cornell University
Summary:
Physicians who prescribe the regular use of beta-agonist drugs for asthma could be endangering their patients, two new studies by researchers at Cornell and Stanford universities find.

ITHACA, N.Y. -- Physicians who prescribe the regular use of beta-agonist drugs for asthma could be endangering their patients, two new studies by researchers at Cornell and Stanford universities find. One study compiles previously published clinical trials to conclude that patients could both develop a tolerance for beta-agonists and be at increased risk for asthma attacks, compared with those who do not use the drug at all. The second study shows that beta-agonist use increases cardiac risks, such as heart attacks, by more than two-fold, compared with the use of a placebo.

Related Articles


Furthermore, the researchers say that their analyses lead them to suspect a conflict of interest among scientists who are supported by pharmaceutical companies that make beta-agonists, among the world's most widely used drugs. This conflict, they say, could be putting 16 million U.S. asthma sufferers in harm's way. Their statement comes as the American Medical Association is voicing its concerns that drug industry sponsorship of clinical tests is affecting the quality of research.

The first study (a meta-analysis, meaning a study of other previously published studies) of more than a dozen research papers on the respiratory effects of beta-agonists is published in the journal, Annals of Internal Medicine (May, 2004), by Shelley R. Salpeter, M.D., Thomas M. Ormiston, M.D., and Edwin E. Salpeter. The second meta-analysis pooled the results from 33 trials on the cardiac effects of beta-agonists, and is published in Chest ( June, 2004), the cardiopulmonary and critical-care journal.

Edwin Salpeter, the eminent astrophysicist who is professor of physics emeritus at Cornell, has turned his interest to medical issues in recent years. He assisted his daughter, Shelley, by performing statistical analyses for asthma drug studies. Shelley Salpeter is a clinical professor of medicine at Stanford University School of Medicine and a physician at Santa Clara Valley Medical Center in San Jose, Calif., where Ormiston also is a physician.

Adrenergic beta-agonists, such as albuterol and terbutaline, work on receptors located on smooth muscles and inflammatory cells in the lungs. These bronchodilator medicines can relax the muscles around the airways that constrict during an asthma attack. Short-term use of beta-agonists has been shown to be helpful in reducing symptoms associated with acute asthma attacks. But continuous use of beta-agonists is a riskier proposition, the authors suggest in their Internal Medicine article.

"Almost all the scientifically valid studies we examined associated continuous beta-agonist use by asthma patients with a decreased bronchodilator response to subsequent beta-agonist administration, and with increased airway inflammation compared to placebo use," says Shelley Salpeter. Continuous use of beta-agonist drugs cause asthma patients to develop a tolerance for the drugs, she adds, making beta-agonists less effective in true emergencies.

Edwin Salpeter questions why so many physicians ignore warning signs of beta-agonist overuse, and why drug companies continue to promote the products for continuous use. "We think the studies warning of adverse respiratory effects are getting lost among the dozens of poor-quality studies that missed the point," he says.

Most studies of continuous use of the drugs that showed favorable results were eliminated from the Salpeter-Ormiston-Salpeter meta-analysis because Cornell and Stanford researchers considered them to be scientifically flawed -- in part because they allowed the as-needed use of beta-agonists in the placebo groups of clinical trials.

Most of these "poor-quality studies" that were eliminated from the meta-analysis, the three researchers say, also turned out to involve conflicts of interest -- because the studies were funded by pharmaceutical companies, because researchers had financial ties to the industry, or both.

"If you want to push continuous use of beta-agonists, you'll find plenty of published studies to back your point of view," Shelley Salpeter says. "However, because of their flawed study designs, none of these trials were truly placebo-controlled and therefore should not be used to make valid conclusions about the safety of beta-agonists. We worry that physicians who recommend regular use of beta-agonists may actually be putting their patients at risk."

To make matters worse, beta-agonist use in patients with asthma and chronic obstructive lung disease also increases the risk for adverse cardiac events (such as heart attacks) by over two-fold compared to placebos, the Cornell-Stanford researchers warn. Beta-agonists work on receptors found in the heart, to increase the heart rate and decrease the level of the essential element potassium. These effects are the exact opposite of beta-blocker drugs, such as atenolol, that often are used in patients with heart disease to decrease their risk for heart attacks and congestive heart failure.

In the spirit of full disclosure, the meta-analysis authors say they have no ties whatsoever to the pharmaceutical industry. In the course of the meta-analyses, Ormiston and Shelley Salpeter received salary support from Santa Clara Valley Medical Center. Edwin Salpeter received no support from Cornell. He did the statistical analysis work, he says, "just for the fun of it, and because I want to see good science rise to the top."


Story Source:

The above story is based on materials provided by Cornell University. Note: Materials may be edited for content and length.


Cite This Page:

Cornell University. "Regular Use Of Asthma Drugs Poses Respiratory, Cardiac Dangers." ScienceDaily. ScienceDaily, 18 June 2004. <www.sciencedaily.com/releases/2004/06/040618063513.htm>.
Cornell University. (2004, June 18). Regular Use Of Asthma Drugs Poses Respiratory, Cardiac Dangers. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2004/06/040618063513.htm
Cornell University. "Regular Use Of Asthma Drugs Poses Respiratory, Cardiac Dangers." ScienceDaily. www.sciencedaily.com/releases/2004/06/040618063513.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins